New Study Reveals How a Toxic Protein Fuels Alzheimer's Progression

New Study Reveals How a Toxic Protein Fuels Alzheimer's Progression

Christina Sanchez
Christina Sanchez
2 Min.
A close-up of a piece of paper with a black background, resembling a micrograph of a human brain, with text at the top and bottom reading "immunohistochemistry formalin/pfa-fixed paraffin-embedded sections - anti-pfa1 antibody [epr22828] - bsa".

New Study Reveals How a Toxic Protein Fuels Alzheimer's Progression

A new study has uncovered how poly-serine, a protein linked to neurodegenerative diseases, actively damages brain cells. Researchers found that this substance does more than signal illness—it directly harms neurons and speeds up disease progression in mice. The findings suggest poly-serine plays a key role in conditions like Alzheimer's by worsening the effects of another toxic protein, tau.

In Alzheimer's disease, tau protein normally detaches from cell structures, changes chemically, and forms harmful clumps. These sticky aggregates disrupt brain function and kill neurons over time. But poly-serine appears to make the problem worse.

Scientists used modified viruses to introduce poly-serine into mice brains. The results were striking: the animals developed motor and cognitive impairments. Further tests showed the protein triggered the loss of Purkinje cells in the cerebellum, which are essential for coordinating movement. Mice exposed to poly-serine also died earlier than expected, indicating the protein accelerates disease progression.

Unlike previous assumptions, poly-serine is not just a bystander in neurodegeneration. Instead, it acts as an active toxin that boosts tau's harmful effects. The protein's domains encourage the formation of toxic clumps, making it a potential driver of diseases like Alzheimer's.

The study highlights poly-serine as a critical factor in worsening neurodegenerative conditions. Researchers are now investigating treatments that could block its interaction with tau, aiming to slow disease progression. While specific drugs are still under exploration, targeting this mechanism may offer a new way to combat Alzheimer's and similar disorders.

Neueste Nachrichten